EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022

Huma Qureshi, Hassan Mahmood, Zubair Nasir, Saad Siddique, Francisco Averhoff, Gavin Cloherty

Journal of Viral Hepatitis · 2024

DOI: 10.1111/jvh.13953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Huma Qureshi und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Focal Point Hepatitis for Pakistan, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis C, Hepacivirus, Police. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Laboratories.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus core antigen (HCVcAg) testing can simplify and decrease costs of HCV infection confirmation compared to molecular testing (nucleic acid testing). We piloted HCVcAg testing for the confirmation of active infection. The study was conducted during June through December 2022 among the police and the general population of Islamabad, Pakistan age 18 years and older. Initial screening for HCV antibody was conducted using a rapid diagnostic test (RDT) for all consenting participants. Those who tested positive had venous blood samples tested for HCVcAg, platelets and aspartate aminotransferase (AST). Persons with HCVcAg values ≥3 fmol/L were defined as viremic, and they were offered treatment with direct acting antiviral (DAA) medications, sofosbuvir and daclatasvir. Aspartate aminotransferase to platelet ratio index (APRI) was calculated for each HCV infected person, and those with an APRI score

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepatitis CHepacivirusPoliceHumansPakistanMaleFemaleAdultMiddle AgedYoung AdultViral Core ProteinsHepatitis C AntigensAgedAdolescentPilot ProjectsMass ScreeningHepatitis C AntibodiesCarbamatesImidazolesPyrrolidinesValine

Stichwörter der Autor:innen

HCVantiviral agentsdaclatasvirhepatitis C testingmolecular diagnostic techniquespilot projectspolicerapid diagnostic testssofosbuvirurban population

Substanzen

Antiviral AgentsViral Core ProteinsHepatitis C AntigensHepatitis C Antibodiesdaclatasvirnucleocapsid protein, Hepatitis C virusCarbamatesImidazolesPyrrolidinesValine

Autor:innen und Institutionen

  • National Focal Point Hepatitis for Pakistan, Islamabad, Pakistan.
  • Hepatitis Planning, Development and Monitoring Unit (PDMU), Islamabad, Pakistan.
  • Citilab, Islamabad, Pakistan.
  • Core Diagnostics, Abbott Pakistan, Karachi, Pakistan.
  • Infectious Disease Research Abbott and the Abbott Pandemic Defense Coalition (APDC), Abbott Park, IL, USA.

Förderung

  • Abbott Laboratories

Zitieren

APA

Qureshi, H., Mahmood, H., Nasir, Z., Siddique, S., Averhoff, F., & Cloherty, G. (2024). A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13953

Vancouver

Qureshi H, Mahmood H, Nasir Z, Siddique S, Averhoff F, Cloherty G. A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13953

BibTeX
@article{Qureshi2024,
  author = {Qureshi, Huma and Mahmood, Hassan and Nasir, Zubair and Siddique, Saad and Averhoff, Francisco and Cloherty, Gavin},
  title = {A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022},
  journal = {Journal of Viral Hepatitis},
  year = {2024},
  doi = {10.1111/jvh.13953}
}
Kostenlos starten →